Cart
sales@molnova.com
MK-0159
CAS No. 2641484-61-7
MK-0159( —— )
Catalog No. M35606 CAS No. 2641484-61-7
MK-0159 is an orally available, highly potent CD38 inhibitor with myocardial injury protection for the study of cardiac ischemia and reperfusion injury.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 72 | In Stock |
|
| 5MG | 117 | In Stock |
|
| 10MG | 170 | In Stock |
|
| 25MG | 283 | In Stock |
|
| 50MG | 412 | In Stock |
|
| 100MG | 609 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMK-0159
-
NoteResearch use only, not for human use.
-
Brief DescriptionMK-0159 is an orally available, highly potent CD38 inhibitor with myocardial injury protection for the study of cardiac ischemia and reperfusion injury.
-
DescriptionMK-0159 is an orally active, potent and selective CD38 inhibitor, with IC50 values of 22, 3, and 70 nM for human, mouse and rat CD38, respectively. MK-0159 also shows good microsomal stability for human and rodent liver microsomes. MK-0159 increases NAD+ (nicotinamide adenine dinucleotide) and reduces ADPR (adenosine diphosphate ribose) in whole blood and heart.
-
In Vitro——
-
In VivoAnimal Model:Cardiac I/R injury miceDosage:30 mg/kg Administration:p.o.Result:Reduced infarct size, and the combination of MK-0159 and NAD+ precursor significantly reduced the infarct size compared to MK-0159 alone.Increased whole heart NAD+ levels and decreased ADPR in the heart.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorCD38
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2641484-61-7
-
Formula Weight400.495
-
Molecular FormulaC20H24N4O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (249.69 mM; Ultrasonic )
-
SMILESCOCCO[C@H]1CC[C@@H](CC1)NC(=O)c1cc(nc2[nH]ccc12)-c1cncs1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lagu B, et al. Orally Bioavailable Enzymatic Inhibitor of CD38, MK-0159, Protects against Ischemia/Reperfusion Injury in the Murine Heart. J Med Chem. 2022 Jun 28. ?
molnova catalog
related products
-
ACT-389949
ACT-389949 is a potent and selective agonist of formyl peptide receptor type 2 (FPR2)/Lipoxin A4 receptor (ALX), with an EC50 of 3 nM for FPR2/ALX internalization into monocytes.
-
5-Hydroxy-3,6,7,4-te...
5-Hydroxy-3,6,7,4'-tetramethoxyflavone is a natural product for research related to life sciences.
-
Delphinidin-3-O-rham...
Delphinidin-3-O-rhamnoside chloride is a natural product for research related to life sciences.
